U

Antitachycardia Pacing and VT Termination: Fact or Fancy?

By Ulrika Birgersdotter-Green
977 views
August 4, 2021
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
18:00
ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky
16:31
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Cardiac Sarcoidosis: Improving Diagnosis and Management

Feat. B. Chung
02:37
Boston Scientific

Positioning Can in the Pocket: S-ICD Implant Best Practices (8 of 8)

Feat. I. Almasry
02:44
Boston Scientific

LUX-Dx ICM Tachycardia Algorithm

01:02
Boston Scientific

How the LUX-Dx ICM Morphology Assessment Works

Feat. D. Perschbacher
04:48
Boston Scientific

Engineered for Advance Control

Feat. D. Perschbacher, S. Vanderline, J. Kelly, S. Saha
04:22
CVRx | Barostim

Barostim Patient Identification

Feat. R. Canby
57
Boston Scientific

Tailor LUX-Dx ICM Program Settings Remotely

Feat. D. Perschbacher
36:07
Scripps Health

Disparities in Care: Pacer/ICD/CRT in WOMEN - a 2023 Update

Feat. J. Rogers
09:39
CVRx | Barostim

Unmet Needs and Device Therapies in HFrEF

Feat. J. Singh
07:41
CVRx | Barostim

New Options for Heart Failure Patients with Narrow QRS

Feat. J. Singh
10:09
Boston Scientific

Effects of ICD Leads on the Tricuspid Valve and Right Ventricle: A R…

Feat. D. Leong
18:30
ACC 2023 Conference Coverage

ACC 2023: Managing ICDs and CRTs in Patients With LVADs

Feat. R. Gopinathannair
18:58
Boston Scientific

Part 3 of 3: UNTOUCHED Trial Results

Feat. M. Gold, U. Birgersdotter-Green
12:34
CVRx | Barostim

The Need for Device Therapy in HFrEF

Feat. W. Abraham
19:17
CVRx | Barostim

EP Lab Digest Panel Q&A

Feat. J. Lindenfeld, R. Canby, N. Raval, B. Knight
03:01
BD

Patient Story: The use of Absorbable Hemostats to Control Bleeding i…

08:28
10th Annual California Heart Rhythm Symposium

Debate: Should VT Ablation Be the First Line Therapy Before ICD Impl…

Feat. W. Sauer
06:09
CVRx | Barostim

The Need for New Device Therapies in HFrEF

Feat. J. Singh